Published in Biomed Res Int on March 28, 2016
Quantification of Retinal Microvascular Density in Optical Coherence Tomographic Angiography Images in Diabetic Retinopathy. JAMA Ophthalmol (2017) 0.75
Macroglia-derived thrombospondin 2 regulates alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure. PLoS One (2017) 0.75
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A (2002) 8.10
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation (2004) 6.90
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82
Descemet-stripping automated endothelial keratoplasty. Cornea (2006) 4.83
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis (2012) 4.42
A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res (2007) 4.34
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov (2006) 4.03
Big-bubble technique to bare Descemet's membrane in anterior lamellar keratoplasty. J Cataract Refract Surg (2002) 3.66
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology (2014) 3.50
Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg (2005) 3.24
The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil (2010) 3.20
Diabetic retinopathy. Diabetes Care (2004) 2.97
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A (1996) 2.67
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol (2007) 2.53
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study. Ophthalmology (2011) 2.47
Epithelial ingrowth after laser in situ keratomileusis. Am J Ophthalmol (2000) 2.31
Simultaneous bilateral laser in situ keratomileusis: safety and efficacy. Ophthalmology (1999) 2.13
Aggravation of proliferative diabetic retinopathy after laser in situ keratomileusis. J Cataract Refract Surg (2003) 2.07
Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol (2000) 2.06
Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci (2000) 1.96
Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol (1984) 1.94
Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev (2006) 1.92
The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci (2011) 1.85
Diabetic keratopathy. Trans Am Ophthalmol Soc (1981) 1.82
Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology (1999) 1.73
Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol (1979) 1.69
Trends of penetrating keratoplasty in the United States from 1980 to 2004. Ophthalmology (2006) 1.68
Wide-field assessment of the human corneal subbasal nerve plexus in diabetic neuropathy using a novel mapping technique. Cornea (2012) 1.64
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology (2011) 1.62
Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. J Thromb Haemost (2008) 1.57
Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology (2000) 1.56
Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology (1985) 1.55
Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®). Graefes Arch Clin Exp Ophthalmol (2011) 1.54
Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye (Lond) (2006) 1.51
In Vivo Confocal Microscopy of Corneal Nerves: An Ocular Biomarker for Peripheral and Cardiac Autonomic Neuropathy in Type 1 Diabetes Mellitus. Invest Ophthalmol Vis Sci (2015) 1.49
A femtosecond laser creates a stronger flap than a mechanical microkeratome. Invest Ophthalmol Vis Sci (2006) 1.48
Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology (2001) 1.43
Preliminary clinical results of Descemet membrane endothelial keratoplasty. Am J Ophthalmol (2007) 1.33
Wounding the cornea to learn how it heals. Exp Eye Res (2014) 1.33
A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond) (2014) 1.30
Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study. Ophthalmology (2006) 1.28
Diabetes, metabolic abnormalities, and glaucoma. Arch Ophthalmol (2009) 1.27
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med (2011) 1.26
Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet Med (2011) 1.24
Clinical observations on the corneal thickness and the corneal endothelium in diabetes mellitus. Br J Ophthalmol (1981) 1.24
Microvascular modifications in diabetic retinopathy. Curr Diab Rep (2011) 1.24
In vivo confocal microscopy of posterior polymorphous dystrophy. Cornea (2005) 1.23
Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis (2011) 1.18
A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt (1988) 1.18
Contact lens-induced changes in the anterior eye as observed in vivo with the confocal microscope. Prog Retin Eye Res (2007) 1.16
Corneal sensitivity in diabetics. Arch Ophthalmol (1974) 1.16
Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.15
Angiogenic Factors and Cytokines in Diabetic Retinopathy. J Clin Cell Immunol (2013) 1.15
In vivo confocal microscopy of corneal small fiber damage in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol (2010) 1.14
The use of the femtosecond laser in the customization of corneal flaps in laser in situ keratomileusis. Curr Opin Ophthalmol (2007) 1.14
Laser scanning in vivo confocal microscopy reveals reduced innervation and reduction in cell density in all layers of the keratoconic cornea. Invest Ophthalmol Vis Sci (2008) 1.14
Deep lamellar keratoplasty using viscoelastic dissection. Arch Ophthalmol (1999) 1.14
Intraocular implants for extended drug delivery: therapeutic applications. Adv Drug Deliv Rev (2006) 1.13
Diabetic Retinopathy: Vascular and Inflammatory Disease. J Diabetes Res (2015) 1.13
Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study. Ophthalmology (2007) 1.13
Diabetes: Advances in Diagnosis and Treatment. JAMA (2015) 1.12
Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol (2008) 1.08
Contact lens sensors in ocular diagnostics. Adv Healthc Mater (2014) 1.08
Trigeminal ganglion neurons affect corneal epithelial phenotype. Influence on type VII collagen expression in vitro. Invest Ophthalmol Vis Sci (1993) 1.08
Comparative study of descemet stripping automated endothelial keratoplasty donor preparation by Moria CBm microkeratome, horizon microkeratome, and Intralase FS60. Cornea (2011) 1.07
Epithelial wound healing in the denervated cornea. Curr Eye Res (1994) 1.07
Advances in the medical treatment of diabetic retinopathy. Diabetes Care (2009) 1.06
Impairment of corneal epithelial barrier function in diabetics. Graefes Arch Clin Exp Ophthalmol (1989) 1.04
Keratoplasty in the United States: A 10-Year Review from 2005 through 2014. Ophthalmology (2015) 1.04
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J Pharm Sci (2010) 1.04
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. Ophthalmology (2014) 1.03
Deviated mechanism of wound healing in diabetic corneas. Cornea (2007) 1.03
Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm (2012) 1.02
Imaging posterior polymorphous corneal dystrophy by in vivo confocal microscopy. Clin Experiment Ophthalmol (2001) 1.02
Progress in corneal wound healing. Prog Retin Eye Res (2015) 1.02
Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol (2002) 1.01
Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye (Lond) (1995) 1.01
Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea (2003) 1.00
Corneal epithelial barrier function in diabetic patients. Cornea (2004) 1.00
Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging (2010) 1.00
Corneal epithelial fragility in diabetes mellitus. Can J Ophthalmol (1995) 0.99
Long-term results of deep anterior lamellar keratoplasty for the treatment of keratoconus. Am J Ophthalmol (2011) 0.99
Sustained-release corticosteroid options. J Ophthalmol (2014) 0.99
Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res (2015) 0.99
A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol (2002) 0.98
Microkeratome-assisted preparation of ultrathin grafts for descemet stripping automated endothelial keratoplasty. Invest Ophthalmol Vis Sci (2012) 0.97
The anesthetic eye: an investigation of changes in the anterior ocular segment of the monkey caused by interrupting the trigeminal nerve at various levels along its course. Trans Am Ophthalmol Soc (1975) 0.97
Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea (2001) 0.97
Ultra-thin donor tissue preparation for endothelial keratoplasty with a double-pass microkeratome. Am J Ophthalmol (2011) 0.96
Predicted biologic activity of intravitreal bevacizumab. Retina (2007) 0.96
Vascular response of the bulbar conjunctiva to diabetes and elevated blood pressure. Ophthalmology (2005) 0.96
Anti-VEGF therapy for diabetic macular edema. Curr Diab Rep (2014) 0.94
Changes of tear film and ocular surface in diabetes mellitus. Korean J Ophthalmol (2004) 0.94
Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol (1983) 0.94
Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery. J Cataract Refract Surg (2008) 0.94